Cargando…

Clinical and Laboratory Characteristics, Neuroimaging Alternations and Treatment Response of 25 HIV-Negative General Paresis Patients

PURPOSE: General paresis is a common type of neurosyphilis featuring progressive cognitive deterioration. The lack of a golden standard of diagnosis and its nonspecific clinical manifestations resulted in a high rate of misdiagnoses. This study aims to investigate the clinical, laboratory and radiol...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Mingjuan, Tong, Meiyi, Zhou, Jia, Lan, Yining, Wu, Mengyin, Zhang, Hanlin, Leng, Ling, Zheng, Heyi, Li, Yanfeng, Li, Mingli, Li, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10624117/
https://www.ncbi.nlm.nih.gov/pubmed/37928605
http://dx.doi.org/10.2147/IDR.S421672
_version_ 1785130858841112576
author Liu, Mingjuan
Tong, Meiyi
Zhou, Jia
Lan, Yining
Wu, Mengyin
Zhang, Hanlin
Leng, Ling
Zheng, Heyi
Li, Yanfeng
Li, Mingli
Li, Jun
author_facet Liu, Mingjuan
Tong, Meiyi
Zhou, Jia
Lan, Yining
Wu, Mengyin
Zhang, Hanlin
Leng, Ling
Zheng, Heyi
Li, Yanfeng
Li, Mingli
Li, Jun
author_sort Liu, Mingjuan
collection PubMed
description PURPOSE: General paresis is a common type of neurosyphilis featuring progressive cognitive deterioration. The lack of a golden standard of diagnosis and its nonspecific clinical manifestations resulted in a high rate of misdiagnoses. This study aims to investigate the clinical, laboratory and radiological presentations of general paresis and enrich its knowledge for timely diagnoses. PATIENTS AND METHODS: The study collected hospitalized patients admitted for general paresis from September 2002 to November 2022. Their socio-demographical and medical status, clinical presentations, cognitive assessments, laboratory and radiographical manifestations and treatment information were collected retrospectively. RESULTS: A total of 20 males and 5 females were included. Patients’ ages ranged from 30 to 66 years (average 50.3 years). The average and median time for diagnosing general paresis was 14.1 months and 10.0 months respectively. The most frequent initial symptom is memory deterioration (68.0%). Impaired calculative ability and memory deterioration were the most frequent cognitive anomalies, as found in 50% and 45.4% of subjects during examination. The mean and median scores of MoCA was 16.7 and 17 respectively. Serological tests revealed positive TPPA for all patients and a median RPR titer at 1:64 positive. All CSF samples with TPPA and FTA-ABS results reported positivity. The MRI manifestations of general paresis include patchy or speckled hyperintensities (70.8%) and cerebral atrophy (45.8%). The most common lesioned sites in MRI were the ventricular and paraventricular area (50.0%) and temporal lobes (45.8%). For treatment, penicillin-based anti-syphilitic plans were adopted in 17 patients (68.0%). CONCLUSION: The clinical features and radiological alternations of general paresis patients often exhibited diverse and nonspecific alternations. However, some specific clinical manifestations and auxiliary examinations can provide meaningful clues for the identification and differential diagnosis of this disease.
format Online
Article
Text
id pubmed-10624117
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-106241172023-11-04 Clinical and Laboratory Characteristics, Neuroimaging Alternations and Treatment Response of 25 HIV-Negative General Paresis Patients Liu, Mingjuan Tong, Meiyi Zhou, Jia Lan, Yining Wu, Mengyin Zhang, Hanlin Leng, Ling Zheng, Heyi Li, Yanfeng Li, Mingli Li, Jun Infect Drug Resist Original Research PURPOSE: General paresis is a common type of neurosyphilis featuring progressive cognitive deterioration. The lack of a golden standard of diagnosis and its nonspecific clinical manifestations resulted in a high rate of misdiagnoses. This study aims to investigate the clinical, laboratory and radiological presentations of general paresis and enrich its knowledge for timely diagnoses. PATIENTS AND METHODS: The study collected hospitalized patients admitted for general paresis from September 2002 to November 2022. Their socio-demographical and medical status, clinical presentations, cognitive assessments, laboratory and radiographical manifestations and treatment information were collected retrospectively. RESULTS: A total of 20 males and 5 females were included. Patients’ ages ranged from 30 to 66 years (average 50.3 years). The average and median time for diagnosing general paresis was 14.1 months and 10.0 months respectively. The most frequent initial symptom is memory deterioration (68.0%). Impaired calculative ability and memory deterioration were the most frequent cognitive anomalies, as found in 50% and 45.4% of subjects during examination. The mean and median scores of MoCA was 16.7 and 17 respectively. Serological tests revealed positive TPPA for all patients and a median RPR titer at 1:64 positive. All CSF samples with TPPA and FTA-ABS results reported positivity. The MRI manifestations of general paresis include patchy or speckled hyperintensities (70.8%) and cerebral atrophy (45.8%). The most common lesioned sites in MRI were the ventricular and paraventricular area (50.0%) and temporal lobes (45.8%). For treatment, penicillin-based anti-syphilitic plans were adopted in 17 patients (68.0%). CONCLUSION: The clinical features and radiological alternations of general paresis patients often exhibited diverse and nonspecific alternations. However, some specific clinical manifestations and auxiliary examinations can provide meaningful clues for the identification and differential diagnosis of this disease. Dove 2023-10-30 /pmc/articles/PMC10624117/ /pubmed/37928605 http://dx.doi.org/10.2147/IDR.S421672 Text en © 2023 Liu et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Liu, Mingjuan
Tong, Meiyi
Zhou, Jia
Lan, Yining
Wu, Mengyin
Zhang, Hanlin
Leng, Ling
Zheng, Heyi
Li, Yanfeng
Li, Mingli
Li, Jun
Clinical and Laboratory Characteristics, Neuroimaging Alternations and Treatment Response of 25 HIV-Negative General Paresis Patients
title Clinical and Laboratory Characteristics, Neuroimaging Alternations and Treatment Response of 25 HIV-Negative General Paresis Patients
title_full Clinical and Laboratory Characteristics, Neuroimaging Alternations and Treatment Response of 25 HIV-Negative General Paresis Patients
title_fullStr Clinical and Laboratory Characteristics, Neuroimaging Alternations and Treatment Response of 25 HIV-Negative General Paresis Patients
title_full_unstemmed Clinical and Laboratory Characteristics, Neuroimaging Alternations and Treatment Response of 25 HIV-Negative General Paresis Patients
title_short Clinical and Laboratory Characteristics, Neuroimaging Alternations and Treatment Response of 25 HIV-Negative General Paresis Patients
title_sort clinical and laboratory characteristics, neuroimaging alternations and treatment response of 25 hiv-negative general paresis patients
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10624117/
https://www.ncbi.nlm.nih.gov/pubmed/37928605
http://dx.doi.org/10.2147/IDR.S421672
work_keys_str_mv AT liumingjuan clinicalandlaboratorycharacteristicsneuroimagingalternationsandtreatmentresponseof25hivnegativegeneralparesispatients
AT tongmeiyi clinicalandlaboratorycharacteristicsneuroimagingalternationsandtreatmentresponseof25hivnegativegeneralparesispatients
AT zhoujia clinicalandlaboratorycharacteristicsneuroimagingalternationsandtreatmentresponseof25hivnegativegeneralparesispatients
AT lanyining clinicalandlaboratorycharacteristicsneuroimagingalternationsandtreatmentresponseof25hivnegativegeneralparesispatients
AT wumengyin clinicalandlaboratorycharacteristicsneuroimagingalternationsandtreatmentresponseof25hivnegativegeneralparesispatients
AT zhanghanlin clinicalandlaboratorycharacteristicsneuroimagingalternationsandtreatmentresponseof25hivnegativegeneralparesispatients
AT lengling clinicalandlaboratorycharacteristicsneuroimagingalternationsandtreatmentresponseof25hivnegativegeneralparesispatients
AT zhengheyi clinicalandlaboratorycharacteristicsneuroimagingalternationsandtreatmentresponseof25hivnegativegeneralparesispatients
AT liyanfeng clinicalandlaboratorycharacteristicsneuroimagingalternationsandtreatmentresponseof25hivnegativegeneralparesispatients
AT limingli clinicalandlaboratorycharacteristicsneuroimagingalternationsandtreatmentresponseof25hivnegativegeneralparesispatients
AT lijun clinicalandlaboratorycharacteristicsneuroimagingalternationsandtreatmentresponseof25hivnegativegeneralparesispatients